Bosnalijek d.d. Sarajevo Logo

Bosnalijek d.d. Sarajevo

Global manufacturer of drugs for digestive, metabolic, and cardiovascular health.

BSNL | SASE

Overview

Corporate Details

ISIN(s):
BABSNLR00005
LEI:
Country:
Bosnia and Herzegovina
Address:
Jukićeva 53, 71000 Sarajevo
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1951, Bosnalijek is a major industrial manufacturer of pharmaceuticals. The company develops and produces a wide portfolio of high-quality medications for peroral, parenteral, and topical applications, targeting conditions related to the digestive system, metabolism, and cardiovascular system. With a presence in more than 20 international markets, Bosnalijek's quality assurance system adheres to stringent national and international Good Manufacturing Practice (GMP) standards. The company's strategy is centered on modernizing its facilities, advancing knowledge, and investing in new technologies to drive innovation within the industry.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Bosnalijek d.d. Sarajevo filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bosnalijek d.d. Sarajevo

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bosnalijek d.d. Sarajevo via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alzinova AB Logo
Developing targeted immunotherapies, including a vaccine, for Alzheimer's disease.
Sweden
ALZ
AMARIN CORP PLC\UK Logo
Develops prescription therapies like Vascepa® to reduce cardiovascular risk for patients.
United States of America
AMRN
AMGEN INC Logo
Biotech pioneer developing innovative human therapeutics for the world's toughest diseases.
United States of America
AMGN
Biotech firm using enzyme tech for pharma, healthcare, and bioprocess CDMO services.
South Korea
092040
AMICUS THERAPEUTICS, INC. Logo
Develops advanced therapies for rare lysosomal storage disorders.
United States of America
FOLD
AMINOLOGICS CO.,LTD. Logo
Manufactures high-purity chiral amino acids & APIs for pharma, chemical, and food industries.
South Korea
074430
Amneal Pharmaceuticals, Inc. Logo
Develops & commercializes essential medicines: generics, injectables & specialty drugs.
United States of America
AMRX
Amphastar Pharmaceuticals, Inc. Logo
Develops and manufactures complex injectable, intranasal, and inhalation pharmaceutical products.
United States of America
AMPH
Amylyx Pharmaceuticals, Inc. Logo
Developing novel therapies for neurodegenerative diseases like ALS and Wolfram syndrome.
United States of America
AMLX
AN2 Therapeutics, Inc. Logo
Developing novel small molecule drugs for infectious diseases and oncology using boron chemistry.
United States of America
ANTX

Talk to a Data Expert

Have a question? We'll get back to you promptly.